U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C23H30N2O4.H2O
Molecular Weight 416.5106
Optical Activity UNSPECIFIED
Defined Stereocenters 5 / 5
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PHOLCODINE MONOHYDRATE

SMILES

O.[H][C@@]12OC3=C4C(C[C@@]5([H])N(C)CC[C@@]14[C@@]5([H])C=C[C@@H]2O)=CC=C3OCCN6CCOCC6

InChI

InChIKey=VOMHFFCEDKOLBR-RNFKYSJUSA-N
InChI=1S/C23H30N2O4.H2O/c1-24-7-6-23-16-3-4-18(26)22(23)29-21-19(5-2-15(20(21)23)14-17(16)24)28-13-10-25-8-11-27-12-9-25;/h2-5,16-18,22,26H,6-14H2,1H3;1H2/t16-,17+,18-,22-,23-;/m0./s1

HIDE SMILES / InChI

Description
Curator's Comment: Description was created based on several sources, including http://www.phadia.com/Global/ImmunoCAP%20Allergens/Product%20Leaflets/Product_Leaflet_c261_Pholcodine.pdf http://www.ncbi.nlm.nih.gov/pubmed/23773349

Pholcodine is an opioid that has been widely used worldwide since 1950 for the treatment of non-productive cough in children and adults. Illicit drug. Additionally Pholcodine is a marker for sensitization to neuromuscular blocking agents (NMBA) and is intended for use as a diagnostic tool in NMBA-induced anaphylaxis.

Originator

Sources: Chabrier, P., Guidicelli, R. & Thuillier, J. (1950) Etude chimique, pharmacologique et clinique d’un nouveau skdatif de la toux: la morpholyethyimorphine (M.E.M.). Annales Pharmaceutiques Francais. 8, 26 1-273.
Curator's Comment: Reference was retrieved from: http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2710.1988.tb00502.x/epdf

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: P33535|||Q64064
Gene ID: 25601.0
Gene Symbol: Oprm1
Target Organism: Rattus norvegicus (Rat)
Target ID: P35372|||G8XRH8|||Q5TDA1|||Q9UN57
Gene ID: 4988.0
Gene Symbol: OPRM1
Target Organism: Homo sapiens (Human)
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Pholcodine Linctus B.P.

Approved Use

Cough
Diagnostic
ImmunoCAP® Allergen c261

Approved Use

Anaphylaxis to neuromuscular blocking agents
PubMed

PubMed

TitleDatePubMed
Angle closure risk from proprietary medicines.
2001 Apr
Impurity profiling of pholcodine by liquid chromatography electrospray ionization mass spectrometry (LC-ESI-MS).
2002 Jan
Interpretation of GC-MS opiate results in the presence of pholcodine.
2002 Jun 25
Enzyme immunoassay validation for the detection of buprenorphine in urine.
2003 Mar
Comparative efficacy and tolerability of pholcodine and dextromethorphan in the management of patients with acute, non-productive cough : a randomized, double-blind, multicenter study.
2006
Site-specific acid-base properties of pholcodine and related compounds.
2006 Nov
Pholcodine exposure raises serum IgE in patients with previous anaphylaxis to neuromuscular blocking agents.
2007 Dec
The pholcodine story.
2009 Aug
Suspected anaphylactic reactions associated with anaesthesia.
2009 Feb
On the origin and specificity of antibodies to neuromuscular blocking (muscle relaxant) drugs: an immunochemical perspective.
2009 Mar
Pholcodine caused anaphylaxis in Sweden 30 years ago.
2009 May

Sample Use Guides

Syrup (1mg/ml pholcodine) Two 5 ml spoonfuls 3 or 4 times a day
Route of Administration: Oral
In Vitro Use Guide
Unknown
Name Type Language
PHOLCODINE MONOHYDRATE
MI  
Common Name English
PHOLCODINE MONOHYDRATE [EP MONOGRAPH]
Common Name English
MORPHINAN-6-OL, 7,8-DIDEHYDRO-4,5-EPOXY-17-METHYL-3-(2-(4-MORPHOLINYL)ETHOXY)-, MONOHYDRATE, (5.ALPHA.,6.ALPHA.)-
Systematic Name English
PHOLCODINE [MART.]
Common Name English
MORPHINAN-6-OL, 7,8-DIDEHYDRO-4,5-EPOXY-17-METHYL-3-(2-(4-MORPHOLINYL)ETHOXY)-, HYDRATE (1:1), (5.ALPHA.,6.ALPHA.)-
Systematic Name English
MORPHINAN-6.ALPHA.-OL, 7,8-DIDEHYDRO-4,5.ALPHA.-EPOXY-17-METHYL-3-(2-MORPHOLINOETHOXY)-, HYDRATE
Systematic Name English
PHOLCODINE MONOHYDRATE [MI]
Common Name English
PHOLCODINE [EP IMPURITY]
Common Name English
3-(2-MORPHOLINOETHYL)MORPHINE MONOHYDRATE
Systematic Name English
Code System Code Type Description
MERCK INDEX
m8711
Created by admin on Sat Dec 16 10:03:31 GMT 2023 , Edited by admin on Sat Dec 16 10:03:31 GMT 2023
PRIMARY Merck Index
EVMPD
SUB52587
Created by admin on Sat Dec 16 10:03:31 GMT 2023 , Edited by admin on Sat Dec 16 10:03:31 GMT 2023
PRIMARY
SMS_ID
100000133620
Created by admin on Sat Dec 16 10:03:31 GMT 2023 , Edited by admin on Sat Dec 16 10:03:31 GMT 2023
PRIMARY
PUBCHEM
86278131
Created by admin on Sat Dec 16 10:03:31 GMT 2023 , Edited by admin on Sat Dec 16 10:03:31 GMT 2023
PRIMARY
FDA UNII
538VG8KNRX
Created by admin on Sat Dec 16 10:03:31 GMT 2023 , Edited by admin on Sat Dec 16 10:03:31 GMT 2023
PRIMARY
CAS
6254-99-5
Created by admin on Sat Dec 16 10:03:31 GMT 2023 , Edited by admin on Sat Dec 16 10:03:31 GMT 2023
PRIMARY